Xenetic Biosciences (XBIO)
NASDAQ:XBIO
Holding XBIO?
Track your performance easily

Xenetic Biosciences (XBIO) Income Statement

289 Followers

Xenetic Biosciences Income Statement

Last quarter (Q1 2024), Xenetic Biosciences's total revenue was $510.82K, an increase of 4.90% from the same quarter last year. In Q1, Xenetic Biosciences's net income was $-1.20M. See Xenetic Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.38M$ 2.54M$ 1.71M$ 1.16M$ 436.94K$ 17.07K
Cost of Revenue
------
Gross Profit
$ 2.38M$ 2.54M$ 1.71M$ 1.16M--
Operating Expense
$ 6.91M$ 7.06M$ 8.42M$ 6.91M$ 5.13M$ 9.62M
Operating Income
$ -5.13M$ -4.52M$ -8.42M$ -6.91M$ -4.69M$ -9.60M
Net Non Operating Interest Income Expense
$ 345.25K$ 355.76K$ 167.15K$ 100.47K$ 126.17K$ 108.49K
Other Income Expense
$ -2.40M$ -2.57M$ -1.71M$ -1.16M$ -9.24M$ -3.28M
Pretax Income
$ -4.16M$ -4.13M$ -6.55M$ -5.65M$ -13.81M$ -12.78M
Tax Provision
----$ -2.92M$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -4.16M$ -4.13M$ -6.55M$ -5.65M$ -10.89M$ -18.06M
Basic EPS
$ -2.22$ -2.71$ -0.46-$ -1.70$ -6.33
Diluted EPS
$ -2.22$ -2.71$ -0.46$ -5.50$ -1.70$ -6.33
Basic Average Shares
$ 19.76M$ 1.53M$ 14.22M$ 1.03M$ 6.39M$ 2.85M
Diluted Average Shares
$ 19.76M$ 1.53M$ 14.22M$ 1.03M$ 6.39M$ 2.85M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 6.91M$ 7.06M$ 8.42M$ 6.91M$ 5.13M$ 9.62M
Interest Expense
------
Net Income From Continuing And Discontinued Operation
$ -4.16M$ -4.13M$ -6.55M$ -5.65M$ -10.89M$ -12.78M
Normalized Income
$ -2.01M$ -3.27M--$ -3.60M$ -9.49M
Ebit
$ -4.21M$ -4.13M$ -6.72M$ -5.75M$ -4.69M$ -9.60M
Ebitda
$ -3.16M$ -4.13M$ -6.69M$ -5.71M$ -4.67M$ -9.58M
Currency in USD

Xenetic Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis